InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Meluzio Michael Vincent. Officer active across 1 company, notably Cue Biopharma, Inc.. Aggregated, 5 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €147k. History available since 9 July 2026. The latest transaction was filed on 13 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations